ScholarLens Back to search
2023•Advances in Leukemia Research and TreatmentOpen access

Comparison of Multiparameter Flow Cytometry and ClonoSEQ Studies for Precursor B-Lymphoblastic Leukemia Minimal Residual Disease Detection on Bone Marrow Samples

Momen Nouran, Tario Joseph, Kai Fu, You‐Wen Qian

Open full text 0 citations

Abstract

Minimal residual disease (MRD) detection for precursor B-lymphoblastic leukemia (B-ALL) has become standard of care. We retrospectively compared MRD evaluation using COG Multiparameteric flow cytometry (MFC) and ClonoSEQ technique to assess the test characteristics.

Open-access reader

About this research paper

What this paper is about

Minimal residual disease (MRD) detection for precursor B-lymphoblastic leukemia (B-ALL) has become standard of care. We retrospectively compared MRD evaluation using COG Multiparameteric flow cytometry (MFC) and ClonoSEQ technique to assess the test characteristics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Minimal residual disease (MRD) detection for precursor B-lymphoblastic leukemia (B-ALL) has become standard of care. We retrospectively compared MRD evaluation using COG Multiparameteric flow cytometry (MFC) and ClonoSEQ technique to assess the test characteristics.

Key concepts: Minimal residual disease, Lymphoblastic Leukemia, Flow cytometry, Bone marrow, Residual, Medicine, Leukemia, Pathology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparison of Multiparameter Flow Cytometry and ClonoSEQ Studies for Precursor B-Lymphoblastic Leukemia Minimal Residual Disease Detection on Bone Marrow Samples — Research Paper | ScholarLens